Jefferies London Healthcare Conference 2023. Panelists seated left to right: LTS Lohmann CEO Bas van Buijtenen, Axplora CEO Sylke Hassel, and Bachem Holding CEO Thomas Meier (Credit: Reynald Castañeda for Endpoints News)
November 17, 2023 11:08 AM EST
Manufacturing

CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

Anna Brown

News Reporter

If there were two key ideas that sprung from the CD­MO pan­el at this week’s Jef­feries Lon­don Health­care Con­fer­ence, it is that man­u­fac­tur­ers are re­view­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

Bris­tol My­ers prunes pipeline amid new round of cost cuts

Bris­tol My­ers launch­es fresh round of ma­jor cost cuts in bid to get ahead of patent cliff

J&J, In­tra-Cel­lu­lar quick­ly sealed $14B deal as three oth­ers passed on buy­ing the neu­ro drug­mak­er

Up­dat­ed: Lil­ly posts 45% sales jump, culls four pro­grams across obe­si­ty, Alzheimer's, heart fail­ure and eczema

A service from the Financial Times